# KYTHERA Biopharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kythera-biopharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Calabasas, US
- Website: www.kytherabiopharma.com
- Total disclosed funding: $97M
- Latest round: Series D (Sep 12, 2011)
- Investors on record: 12

## About

Founded in 2005, KYTHERA Biopharmaceuticals is a privately-held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic market. The aesthetic market is characterized by an aging population, increasing discretionary income and an evolution of patient preference towards care that focuses on quality of life.

## Funding rounds

- Series D, Sep 12, 2011, $37M — ARCH Venture Partners, Prospect Venture Partners, Versant Ventures, JAFCO Group, PFM Capital, Invus [DUP], Altitude Life Science Ventures, Apothecary Capital, VP Company Investments 2008, LLC, Latham & Watkins
- Series C, Jul 1, 2009, $10M — ARCH Venture Partners, Prospect Venture Partners, Versant Ventures, JAFCO Group, PFM Capital, Altitude Life Science Ventures, Apothecary Capital
- Series C, May 16, 2008, $30M — ARCH Venture Partners, Prospect Venture Partners, Versant Ventures, JAFCO Group, PFM Capital, Altitude Life Science Ventures, Apothecary Capital, Wilson Sonsini Goodrich & Rosati
- Series B, May 9, 2006, $20M — ARCH Venture Partners, Prospect Venture Partners, Versant Ventures, Altitude Life Science Ventures, Wilson Sonsini Goodrich & Rosati, UCLA Venture Capital Fund

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series B, Series C, Series D
- Prospect Venture Partners (https://capitalatlas.ai/funds/prospect-venture-partners) — Series B, Series C, Series D
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B, Series C, Series D
- Altitude Life Science Ventures (https://capitalatlas.ai/funds/altitude-life-science-ventures) — Series B, Series C, Series D
- Wilson Sonsini Goodrich & Rosati — Series B, Series C
- UCLA Venture Capital Fund (https://capitalatlas.ai/funds/ucla-venture-capital-fund) — Series B
- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series C, Series D
- PFM Capital (https://capitalatlas.ai/funds/pfm-capital) — Series C, Series D
- Apothecary Capital — Series C, Series D
- Invus [DUP] — Series D
- VP Company Investments 2008, LLC — Series D
- Latham & Watkins — Series D